SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma

被引：0
|
作者：
Jian Wu
Min Zhang
Omar Faruq
Eldad Zacksenhaus
Wenming Chen
Aijun Liu
Hong Chang
机构：
[1] University of Toronto,Department of Laboratory Medicine and Pathobiology
[2] Capital Medical University,Department of Hematology, Beijing Chaoyang Hospital
[3] University Health Network,Department of Laboratory Hematology, Laboratory Medicine Program
来源：
Biomarker Research | / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma
    Wu, Jian
    Zhang, Min
    Faruq, Omar
    Zacksenhaus, Eldad
    Chen, Wenming
    Liu, Aijun
    Chang, Hong
    BIOMARKER RESEARCH, 2021, 9 (01)
  • [2] Cdc42: A New therapeutic target in drug-resistant multiple myeloma
    Thi Thuy Phuong Nguyen
    Chakrabart, Jayati
    Guo, Fukun
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [3] SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy
    Gerlach, Magdalena M.
    Stelling-Germani, Anna
    Wu, Cheuk Ting
    Newrzela, Sebastian
    Doring, Claudia
    Vela, Visar
    Muller, Anne
    Hartmann, Sylvia
    Tzankov, Alexandar
    HAEMATOLOGICA, 2021, 106 (02) : 619 - 621
  • [4] BET bromodomain degradation as a therapeutic strategy in drug-resistant multiple myeloma
    Matthews, Geoffrey M.
    Hu, Yiguo
    Sheffer, Michel
    Hengeveld, Paul J.
    Buckley, Dennis L.
    Bariteau, Megan A.
    Poarch, Haley
    Bradner, James E.
    Mitsiades, Constantine S.
    CANCER RESEARCH, 2016, 76
  • [5] Combined treatment for drug-resistant multiple myeloma?
    Burton, A
    LANCET ONCOLOGY, 2005, 6 (07): : 447 - 447
  • [6] Autophagy: A Potential Therapeutic Target to Tackle Drug Resistance in Multiple Myeloma
    Bashiri, Hamed
    Tabatabaeian, Hossein
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [7] Smad1 as a biomarker for diabetic nephropathy
    Kato, Hideki
    Si, Han
    Hostetter, Thomas
    Susztak, Katalin
    DIABETES, 2008, 57 (06) : 1459 - 1460
  • [8] Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma
    Raninga, Prahlad V.
    Di Trapani, Giovanna
    Vuckovic, Slavica
    Bhatia, Maneet
    Tonissen, Kathryn F.
    ONCOTARGET, 2015, 6 (17) : 15410 - 15424
  • [9] LncRNA as potential target in drug-resistant melanomas
    Esteve-Puig, Rosaura
    Sanlorenzo, Martina
    Vujic, Igor
    Lai, Kevin
    Vujic, Marin
    Mould, Dallas
    Lin, Kevin
    Oses-Prieto, Juan
    Chand, Shreya
    Posch, Christian
    Burlingame, Alma
    Ortiz-Urda, Susana
    CANCER RESEARCH, 2017, 77
  • [10] Combination therapy for treating drug-resistant multiple myeloma
    Kim, Byung-Gyu
    Choi, Sung Hee
    Luo, George
    Kim, Seong-Jin
    Malek, Ehsan
    Driscoll, James
    Letterio, John
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
12345